Relay Therapeutics (RLAY) Return on Capital Employed Growth (1y) (2021 - 2026)

Relay Therapeutics (RLAY) Return on Capital Employed Growth (1y) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE Growth (1y) (Qtr)
1 Oculis Holding AG 68,725.60 Bn 68,725.31 Bn - 1,648.00
2 Nanobiotix 1,953.19 Bn 1,953.13 Bn - -
3 Akari Therapeutics 1,132.35 Bn 1,132.35 Bn - 31,429.00
4 BeOne Medicines 472.73 Bn 467.94 Bn 1.35 Bn 1,805.00
5 Vertex Pharmaceuticals 123.52 Bn 116.27 Bn 2.59 Bn 2,503.00
6 Regeneron Pharmaceuticals 69.74 Bn 60.99 Bn 3.31 Bn -105.00
7 Belite Bio 63.09 Bn 63.09 Bn - -
8 Argenx Se 56.42 Bn 51.24 Bn 1.41 Bn -
9 Revolution Medicines 37.76 Bn 37.76 Bn - -3,457.00
10 Relay Therapeutics 3.41 Bn 3.41 Bn - -103.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -103.00
Dec 31, 2025 -500.00
Sep 30, 2025 -185.00
Jun 30, 2025 -5.00
Mar 31, 2025 -101.00
Dec 31, 2024 31.00
Sep 30, 2024 -719.00
Jun 30, 2024 -741.00
Mar 31, 2024 -1,113.00
Dec 31, 2023 -1,618.00
Sep 30, 2023 -930.00
Jun 30, 2023 -868.00
Mar 31, 2023 724.00
Dec 31, 2022 4,799.00
Sep 30, 2022 -97,125.00
Jun 30, 2022 3,514.00
Mar 31, 2022 -3,175.00
Dec 31, 2021 -6,862.00
Sep 30, 2021 96,237.00